Results 61 to 70 of about 8,658 (209)
Successful Treatment of Scalp Myxedema with Injected Hyaluronidase: A Case Report
Localized myxedema is an uncommon complication of Graves’ disease. It is characterized by the accumulation of glycosaminoglycans, particularly hyaluronate.
Sébastien Menzinger, Gürkan Kaya
doaj +1 more source
Abstract Breast cancer is a common, survivable malignancy affecting women. With improved survival, the off‐target effects of chemotherapy, such as a decline in cardiorespiratory fitness and worse cardiovascular outcomes, have been recognized. Exercise training may help mitigate these effects.
Nathan R. Weeldreyer +12 more
wiley +1 more source
Elephantiasic Pretibial Myxedema: A Rare Manifestation in Graves’ Disease
Elephantiasic pretibial myxedema is an extremely rare condition, affecting patients with thyroid disease. The clinical manifestation is difficult to diagnosis, and the treatment is challenging.
Apichat Kaewdech +5 more
doaj +1 more source
This report describes a case of syndrome of inappropriate antidiuretic hormone secretion (SIADH) in a Maltese with meningoencephalitis of unknown etiology (MUE). The dog was treated with water restriction and tolvaptan, a vasopressin receptor antagonist, which resulted in an improvement in hyponatremia.
Yelim Lee +5 more
wiley +1 more source
The Treatment of Myxedema [PDF]
n ...
openaire +1 more source
Heat stroke is a life‐threatening emergency characterized by severe hyperthermia and acute central nervous system (CNS) dysfunction. We describe a 72‐year‐old man who was found unresponsive in his vehicle on a day with ambient temperatures exceeding 90°F. On arrival, his core temperature was 105.8°F, and Glasgow Coma Scale (GCS) score was 5.
Ryan Sholes +5 more
wiley +1 more source
Non‐Autoimmune Hyperthyroidism Associated With a Novel Germline Mutation (D633N) in the TSH Receptor
Nonautoimmune hyperthyroidism resulting from an activating germline thyroid‐stimulating hormone receptor (TSHR) gene mutation is a rare condition that often presents a diagnostic challenge. We report the case of a 75‐year‐old woman with a 20‐year history of goiter and subclinical hyperthyroidism who presented with overt thyrotoxicosis. Laboratory tests
Sayuri Mori +10 more
wiley +1 more source
Alemtuzumab‐Induced Graves’ Disease Complicated by Pretibial Myxoedema: A Case Report
Background Alemtuzumab, a monoclonal antibody targeting CD52, is associated with a high incidence of secondary autoimmune disease, most commonly thyroid dysfunction. Alemtuzumab‐induced Graves’ disease (AIGD) typically follows a relapsing course and may exhibit atypical or severe phenotypes during immune reconstitution (IR). Case Presentation We report
Aongus O’Brolchain +2 more
wiley +1 more source
Myxedema and Hypothyroidism [PDF]
n ...
openaire +1 more source

